logo
Hamdan Foundation participates in Arab Health Exhibition and Congress 2025

Hamdan Foundation participates in Arab Health Exhibition and Congress 2025

Emirates 24/728-01-2025

Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences participated in the Arab Health Exhibition and Congress 2025, which commenced on Monday at the Dubai World Trade Centre.
The event attracts widespread participation from around the world, bringing together policymakers, experts, and health authorities to exchange knowledge and showcase the latest healthcare technologies and innovations.
Dr. Salama Al Muhairi, Director of Medical Excellence at the Foundation, said, 'Through this event, we aim to achieve strategic objectives that include building sustainable partnerships with global health entities, exchanging outstanding expertise, and exploring innovative solutions to enhance healthcare services.'
The foundation participated as part of the Dubai Health Authority's pavilion to enhance its interaction with partners and stakeholders in the healthcare sector and strengthen international collaboration to achieve sustainable and impactful advancements in the healthcare sector.
Follow Emirates 24|7 on Google News.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Prozac users in the UAE concerned as supplies of 'life-changing' drug run out
Prozac users in the UAE concerned as supplies of 'life-changing' drug run out

The National

timea day ago

  • The National

Prozac users in the UAE concerned as supplies of 'life-changing' drug run out

Concerns are growing among Prozac users in the UAE around dwindling supplies of the drug after its global discontinuation last year. Pharmaceutical giant Lilly decided to cease production of the medication due to "evolving business priorities", however it has left patients and psychiatrists in the Emirates worrying about either how to source the drug internationally, or finding an alternative. Considered a cornerstone treatment for conditions like depression and anxiety, the medication is now fast disappearing from pharmacy shelves as stocks run out. Internationally, the medication is widely available under other brand names however in the UAE Prozac has historically been the only option with this formula. Finding alternatives Prozac, originally manufactured by US drug company Lilly, is the brand name for fluoxetine, a type of medication known as a selective serotonin reuptake inhibitor (SSRI). It has been used for mental health conditions, including depression, anxiety, obsessive-compulsive disorder, premenstrual dysphoric disorder and bulimia nervosa since its launch in 1987. It is available on the market as a controlled medication and accessible to patients when prescribed by a psychiatrist. Now, patients may have to source their medication out of the country or try alternative pharmaceuticals, such as Zoloft (sertraline) or Cipralex (escitalopram), which have different base formulations and therefore different side effects depending on a person's biology. 'This decision is not related to the safety or efficacy of the medicine, but reflects the availability of broad alternative treatments and evolving business priorities,' a Lilly spokesperson told The National. 'We encourage patients currently on Prozac to speak to their healthcare provider about treatment options available to them. While no new supplies are being planned, limited stock may still be available locally through licensed distributors.' The National was able to locate some Prozac at pharmacies with leftover stocks at the time of writing, but many contacted were completely out. Global antidepressants usage While Prozac has been one of the most widely prescribed drugs of its kind for decades, the global antidepressant market is growing rapidly. It was valued at $18.7 billion in 2024 and is estimated to increase at a compound annual growth rate of 7.5 per cent from 2025 to 2034, when it is forecasted it will be worth $37.9 billion, according to Global Market Insights. This is being driven predominantly by mental health awareness and rising demand for effective treatments for various conditions. 'Impact was life-changing' One Dubai-based mother, who wished to remain anonymous, is concerned for her 11-year-old daughter, who has been taking Prozac for the past 18 months. "She is autistic and struggles with severe anxiety, OCD and specific phobias," she told The National. "We tried other SSRIs before, but none were effective. Prozac has been the only medication that made a noticeable difference, particularly for her OCD symptoms." The mother said since they'd heard Prozac is going out of stock in the UAE, they've been trying to source an alternative fluoxetine product from their home country. "Switching to another SSRI is not a viable option for her right now ... I trust that the authorities will take this matter seriously and work toward a solution, especially for children and families who rely on this medication for daily functioning and well-being." Dubai resident Victoria McKeown, who lived with 'crippling' anxiety for years until she was prescribed Prozac, is also concerned about the lack of availability in the future. 'While I wouldn't describe myself as clinically depressed, I tried several antidepressants over the years with little effect,' she told The National. 'That changed when I was prescribed a low dose of Prozac. The impact was life-changing – not just for me, but for those around me.' Ms McKeown's psychiatrist contacted her to say she will need to consider trying medications that had previously been ineffective. 'Right now, it seems my only option is to travel overseas, obtain a prescription there, and bring it back with me," she said. "It's incredibly disheartening that a medication which has helped so many people is no longer available here.' Experts are hopeful that an appropriate alternative will soon be available in the market, however. Dr Teizeem Dhanji, a child and adolescent psychiatrist and medical director at Dubai's Sage Clinics, said there is currently no confirmed guidance from authorities, but 'it is expected that substitute options will be introduced in due course'. The National has contacted the Emirates Drug Establishment for more details on when an alternative will be registered, but there was no confirmation at the time of writing. What patients can do now Dr Dhanji advised individuals taking fluoxetine to consult their treating psychiatrists to discuss the best course of action. 'Clinicians can help develop a personalised plan to safely and gradually taper the current medications and transition to an appropriate alternative if necessary," she said. "There are a number of safe and effective antidepressant options available in the UAE and so patients should consult their psychiatrist early.' It may also give some individuals the chance to reassess treatment needs and explore additional coping strategies or therapeutic options that may complement or replace medication, Dr Dhanji added. But the disruption could have a significant impact on the market, said Antony Bainbridge, head of clinical services and clinical lead at Resicare Alliance, a UK-based assessment and residential provider for children with mental health issues that plans to open a Dubai boarding facility soon. Mr Bainbridge said the lack of a substitute could require potentially disruptive changes in medication, particularly for patients who respond well to fluoxetine. 'Alternative SSRIs like sertraline, citalopram and paroxetine are available, but they have different side effect profiles and may not be as effective for every individual.' Patients switching from Prozac to another SSRI may experience withdrawal symptoms, relapse or other side effects during the transition, he added. 'The unavailability may lead to worsening of symptoms in some patients, increasing the burden on mental health services.' Mr Bainbridge also expressed concerns that patients could resort to unregulated or illegal sources to obtain the medication, 'posing significant safety risks'.

Over 4,000 harmful substances: Why even 'just one more cigarette' could be too many
Over 4,000 harmful substances: Why even 'just one more cigarette' could be too many

Khaleej Times

time5 days ago

  • Khaleej Times

Over 4,000 harmful substances: Why even 'just one more cigarette' could be too many

Smokers are often heard saying: "Just one cigarette is not going to do any harm." Or defending smoking habits on the basis that its only "once in a while". However, every cigarette contains an immense amount of harm to the smoker, and their loved ones, who may inhale second-hand smoke. One cigarette contains over 4,000 harmful substances, which includes 94 toxic chemicals, Dubai Health Authority warned. These chemicals are even more dangerous when burned. These chemicals are a major cause of: High blood pressure High cholesterol Cancers (mouth, throat, gums, colon) Asthma and bronchitis Heart attacks, strokes Stomach ulcers Osteoporosis While quitting can be hard, support systems such as family and medical help can assist you in the process. Along with speaking to your loved ones and setting up an appointment, it is essential to stay away from environments that give you the urge to smoke. Setting a quit date and beginning a regular exercise routine can also help, according to DHA. Quitting smoking can greatly improve your quality of life and has many benefits:

Eid Al Adha: Ajman cracks down on food outlets; announces free parking, public park timings
Eid Al Adha: Ajman cracks down on food outlets; announces free parking, public park timings

Khaleej Times

time04-06-2025

  • Khaleej Times

Eid Al Adha: Ajman cracks down on food outlets; announces free parking, public park timings

Ajman has intensified inspection campaigns on food outlets and livestock markets as part of its Eid Al Adha preparations, aiming to safeguard public health and ensure food sold during the holiday meets strict hygiene and safety standards. The Ajman Municipality and Planning Department said round-the-clock inspections are underway at restaurants, butcheries, and health establishments that experience high footfall during Eid. Veterinary teams are also monitoring livestock markets to ensure the health and safety of sacrificial animals before they reach consumers. 'All preparations have been made to ensure a safe and smooth Eid for everyone. Our inspection teams are working around the clock to protect public health and uphold Ajman's quality of life,' said Abdurahman Al Nuaimi, Director General of Ajman Municipality and Planning. Meanwhile, all slaughterhouses across the emirate are fully set to receive sacrificial animals. The facilities have been equipped with modern tools and staffed with skilled veterinary and technical teams to carry out pre- and post-slaughter inspections, in line with international health standards. The central abattoir will open its doors to the public on Arafat Day from 7.30am to 3pm, and on Eid Day immediately after prayers until 4pm. Operations will continue daily through the Eid holidays from 7am to 4pm The Masfout and Al Manama abattoirs will also operate on split shifts to accommodate growing Municipality confirmed that incoming food shipments continue to be screened in collaboration with Ajman Port and Customs. Using the federal ZAD platform, all food containers are inspected thoroughly before clearance. Free parking, festive lights, and open parks Ajman will offer free public parking from June 5 to 8, with regular fees resuming on June 9. The city has also been adorned with 1,050 decorative light panels and greeting banners to reflect the festive spirit. Parks and public facilities will be open to visitors from 4.30pm to 11pm, while Al Rashidiya Park will extend its hours from 3pm to midnight.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store